GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities
YONGIN, South Korea, Jan. 15, 2026 /PRNewswire/ -- GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on...
GCCL Wins 2025 Asia-Pacific Customer Value Leadership Award by Frost & Sullivan
- GCCL's "One-Stop Lab Solution" sets the industry benchmark with unmatched competitiveness and a dedication to global excellence. - Continuing its growth as a globally recognized leader in clinical sample analysis, driven by customer-centric...
GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC
GCCL is committed to customer success, emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research analyses. SAN ANTONIO, Feb. 6, 2025 /PRNewswire/ --...